Cite
HARVARD Citation
Coleman, R. et al. (n.d.). O028/#376 Clinical benefit of mirvetuximab soravtansine in ovarian cancer patients with high folate receptor alpha expression: results from the soraya study. International journal of gynecological cancer. p. A18. [Online].